UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report: July 19, 2019
(Date of earliest event reported)
INTERNATIONAL BUSINESS MACHINES
CORPORATION
(Exact name of registrant as specified in its charter)
New York | 1-2360 | 13-0871985 | ||
(State of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
Armonk, New York | 10504 |
(Address of principal executive offices) | (Zip Code) |
914-499-1900
(Registrant’s telephone number)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading symbol | Name of each exchange on which registered | ||
Capital stock, par value $.20 per share | IBM | New York Stock Exchange Chicago Stock Exchange | ||
1.375% Notes due 2019 | IBM 19B | New York Stock Exchange | ||
2.750% Notes due 2020 | IBM 20B | New York Stock Exchange | ||
1.875% Notes due 2020 | IBM 20A | New York Stock Exchange | ||
0.500% Notes due 2021 | IBM 21B | New York Stock Exchange | ||
2.625% Notes due 2022 | IBM 22A | New York Stock Exchange | ||
1.25% Notes due 2023 | IBM 23A | New York Stock Exchange | ||
0.375% Notes due 2023 | IBM 23B | New York Stock Exchange | ||
1.125% Notes due 2024 | IBM 24A | New York Stock Exchange | ||
2.875% Notes due 2025 | IBM 25A | New York Stock Exchange | ||
0.950% Notes due 2025 | IBM 25B | New York Stock Exchange |
0.875% Notes due 2025 | IBM 25C | New York Stock Exchange | ||
0.300% Notes due 2026 | IBM 26B | New York Stock Exchange | ||
1.250% Notes due 2027 | IBM 27B | New York Stock Exchange | ||
1.750% Notes due 2028 | IBM 28A | New York Stock Exchange | ||
1.500% Notes due 2029 | IBM 29 | New York Stock Exchange | ||
1.750% Notes due 2031 | IBM 31 | New York Stock Exchange | ||
8.375% Debentures due 2019 | IBM 19 | New York Stock Exchange | ||
7.00% Debentures due 2025 | IBM 25 | New York Stock Exchange | ||
6.22% Debentures due 2027 | IBM 27 | New York Stock Exchange | ||
6.50% Debentures due 2028 | IBM 28 | New York Stock Exchange | ||
7.00% Debentures due 2045 | IBM 45 | New York Stock Exchange | ||
7.125% Debentures due 2096 | IBM 96 | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ |
Item 1.01. Entry into a Material Definitive Agreement.
On July 18, 2019, International Business Machines Corporation (“IBM”) extended the maturity of the existing $10.25 billion Amended and Restated Five-Year Credit Agreement dated as of July 19, 2018 (the “Amended and Restated Five-Year Credit Agreement”), among IBM, each Subsidiary Borrower (as defined therein), the several banks and other financial institutions from time to time parties thereto (the “Five-Year Lenders”), JPMorgan Chase Bank, N.A., as Administrative Agent, BNP Paribas, Citibank N.A., Royal Bank of Canada and Mizuho Bank Ltd., as Syndication Agents, and the Documentation Agents named therein pursuant to an extension request as contemplated by the Amended and Restated Five-Year Credit Agreement. On July 18, 2019, IBM and IBM Credit LLC (“IBM Credit”) (IBM and IBM Credit together, the “Borrowers”) (i) entered into a new $2.5 billion 364-Day Credit Agreement (the “New 364-Day Credit Agreement”) with the several banks and other financial institutions from time to time parties thereto (the “364-Day Lenders”) and (ii) extended the maturity of the existing $2.5 billion Amended and Restated Three-Year Credit Agreement dated as of July 19, 2018 (the “Amended and Restated Three-Year Credit Agreement”), among the Borrowers, the several banks and other financial institutions from time to time parties thereto (the “Three-Year Lenders,” together with the Five-Year Lenders and the 364-Day Lenders, the “Lenders”), JPMorgan Chase Bank, N.A., as Administrative Agent, BNP Paribas, Citibank N.A., Royal Bank of Canada and Mizuho Bank Ltd., as Syndication Agents and the Documentation Agents named therein pursuant to an extension request as contemplated by the Amended and Restated Three-Year Credit Agreement.
The New 364-Day Credit Agreement permits the Borrowers to borrow up to an aggregate of $2.5 billion on a revolving basis at any time during the term of the New 364-Day Credit Agreement, subject to the terms therein. Neither Borrower is a guarantor or co-obligor of the other Borrower under the New 364-Day Credit Agreement. Funds borrowed may be used for the general corporate purposes of the Borrowers. Interest rates on borrowings under the New 364-Day Credit Agreement will be based on prevailing market interest rates plus a margin, as further described therein. The New 364-Day Credit Agreement contains customary representations and warranties, covenants, events of default and indemnification provisions. The foregoing description of the New 364-Day Credit Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the New 364-Day Credit Agreement, which is filed as Exhibit 10.1 to this report, and is incorporated by reference herein.
The maturity of each of the Amended and Restated Three-Year Credit Agreement and the Amended and Restated Five-Year Credit Agreement was extended by a period of one year to July 20, 2022 and July 20, 2024, respectively, confirmations of which are filed as Exhibits 10.2 and 10.3 to this report, and are incorporated by reference herein. The terms of the Amended and Restated Three-Year Credit Agreement and the Amended and Restated Five-Year Credit Agreement otherwise remain unchanged.
In the ordinary course of their respective businesses, the Lenders and their affiliates have engaged, and may in the future engage, in commercial banking, investment banking, financial advisory or other services with the Borrowers for which they have in the past and/or may in the future receive customary compensation and expense reimbursement.
Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference herein.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. | Description | |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Date: July 19, 2019 | ||||
By: | /s/ Simon J. Beaumont | |||
Simon J. Beaumont | ||||
Vice President and Treasurer | ||||